• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Legal Officer & Sec. Mitchell John Todd covered exercise/tax liability with 88,769 shares, decreasing direct ownership by 9% to 915,392 units (SEC Form 4)

    4/16/25 7:30:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    MITCHELL JOHN TODD

    (Last) (First) (Middle)
    C/O PACS GROUP, INC.
    262 N. UNIVERSITY AVE.

    (Street)
    FARMINGTON UT 84025

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    PACS Group, Inc. [ PACS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Legal Officer & Sec.
    3. Date of Earliest Transaction (Month/Day/Year)
    04/15/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/15/2025 F(1) 88,769 D $9.35 915,392 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Payment of tax liability through the withholding of securities upon the vesting of previously-granted and reported restricted stock units (RSUs).
    Remarks:
    /s/ John Mitchell 04/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PACS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • PACS Group downgraded by Analyst with a new price target

      Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

      12/17/24 8:16:05 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • JP Morgan resumed coverage on PACS Group with a new price target

      JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

      11/6/24 6:27:46 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • UBS initiated coverage on PACS Group with a new price target

      UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

      10/9/24 7:56:46 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 16,777 shares, decreasing direct ownership by 5% to 326,591 units (SEC Form 4)

      4 - PACS Group, Inc. (0002001184) (Issuer)

      4/16/25 7:32:30 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • Chief Compliance Officer Lee Joseph Robert covered exercise/tax liability with 28,763 shares, decreasing direct ownership by 4% to 648,122 units (SEC Form 4)

      4 - PACS Group, Inc. (0002001184) (Issuer)

      4/16/25 7:31:48 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • Officer Sanford Peter covered exercise/tax liability with 72,924 shares, decreasing direct ownership by 5% to 1,280,872 units (SEC Form 4)

      4 - PACS Group, Inc. (0002001184) (Issuer)

      4/16/25 7:31:05 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care